ClinicalTrials.gg
Enrolling by invitationNCT06816589Updated Mar 17, 2026

Using ChatGPT as a Job Coach for Adults With Autism Spectrum Disorder

An interventional study of ChatGPT-based job coaching in Autism and Job Interview Performance, sponsored by National Taiwan University Hospital. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-03-17.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Oct 2023, registered Feb 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Autistic Disorder by National Taiwan University Hospital — 6 open to participants now, 6 under way, none of them phase 3. Autistic Disorder · National Taiwan University Hospital.

Started
2023
with 1 other
No phase
6 of 12
3 open now
Registered
10th of 12
by date

Among the 12 studies in Autistic Disorder by National Taiwan University Hospital, this one is one of 2 that started in 2023, is one of 6 with no phase, and was the 10th registered.

Autistic Disorder

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

Browse Autistic Disorder studies →

Open to participants now

6 of the 12 studies in Autistic Disorder by National Taiwan University Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Autistic Disorder by National Taiwan University Hospital, or all of them as a file.
02

Study summary

The goal of this clinical trial is to examine the effectiveness of the ChatGPT-based job coach in helping ASD individuals prepare for job application, job interview, and interpersonal skills in workplaces. The main questions aim to answer are:

How can we develop a ChatGPT-based job coach system to assist individuals with autism spectrum disorder (ASD) in job applications, job interviews, and interpersonal skills in workplaces?

How effective is the ChatGPT-based job coach in helping ASD individuals (n=30) prepare for job applications, job interviews, and interpersonal skills in workplaces? What clinical correlates are associated with better effectiveness, and what are the interaction patterns between ASD adults and the ChatGPT platform?

Participants will complete assessment questionnaires (evaluating autism traits and empathy, approximately 30 minutes) and a one-hour job interview practice. Please follow the recommendations to use ChatGPT for completing your job resume, job type discussions, job interview preparation and practice, explanation of Asperger's traits for the workplace, and workplace social discussions. After one week of practice, you will fill out the assessment questionnaires and complete the job interview practice again.

03

Conditions studied

  • Autism
  • Job Interview Performance

Browse trials for

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Young adult aged between 18 and 45 years who had a diagnosis of ASD from a licensed mental health or medical professional based on ;
  • is motivated to have a job
  • is able to use the ChatGPT on the computer under instruction (e.g., typing questions) and is able to provide feedback to the research team
  • has a full-scale IQ > 70 on WAIS-IV
  • scored ≧ 26 on the caregiver-reported Autism Spectrum Quotient (AQ), indicating clinical impairment associated with ASD
  • agree to audio and video recording during the interview rehearsal.

Exclusion criteria

Exclusion Criteria:

  • A history of major psychiatric disorders (e.g., bipolar affective disorder, schizophrenia, or psychosis) or neurological diseases
  • visual impairment and/or hearing impairment that would preclude participation in the study
  • refuse audio and video recording during the interview rehearsal.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Autism

    Behavioral: ChatGPT-based job coaching

Interventions

  • BehavioralChatGPT-based job coaching

    Using ChatGPT for creating job resumes, discussing job types, preparing and practicing for job interviews, writing job descriptions for individuals with Asperger's syndrome, and discussing workplace social interactions

06

What researchers measure

Primary outcomes

  1. the score of job interview role-play performance (JIRP)

    Time frame: 1 hour

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Dec 2026, 38 months after the start.

Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 38 months is above that.

Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 4, 2025
First posted
Feb 10, 2025
StartActual
Oct 1, 2023
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Mar 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06816589
Responsible party
Sponsor
First posted
Feb 10, 2025
Start date
Oct 1, 2023
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Mar 17, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion